Characterization of the role of nitric oxide and its clinical applications

AB Levine, D Punihaole, TB Levine - Cardiology, 2012 - karger.com
Nitric oxide (NO) has long been known as endothelium-derived relaxing factor. It is a
vasodilator, modulating vascular tone, blood pressure and hemodynamics, a role exploited …

Inflammatory lipid mediators in adipocyte function and obesity

A Iyer, DP Fairlie, JB Prins, BD Hammock… - Nature Reviews …, 2010 - nature.com
Survival of multicellular organisms depends on their ability to fight infection, metabolize
nutrients, and store energy for times of need. Unsurprisingly, therefore, immunoregulatory …

Poor oral health and blood pressure control among US hypertensive adults: results from the national health and nutrition examination survey 2009 to 2014

D Pietropaoli, R Del Pinto, C Ferri, JT Wright Jr… - …, 2018 - Am Heart Assoc
Periodontal disease is a chronic inflammatory disorder of the tissues surrounding the teeth,
with evidence of systemic effects. Some studies showed the benefit of periodontal therapy …

Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food

F De Leo, S Panarese, R Gallerani… - Current pharmaceutical …, 2009 - ingentaconnect.com
In recent decades, the most successful strategy for controlling blood pressure has been
inhibition of the angiotensin-converting enzyme (ACE). ACE inhibitors of chemical synthesis …

Pharmacogenomics and hypertension: current insights

GH Oliveira-Paula, SC Pereira… - Pharmacogenomics …, 2019 - Taylor & Francis
Hypertension is a multifactorial disease that affects approximately one billion subjects
worldwide and is a major risk factor associated with cardiovascular events, including …

Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness

C Koumaras, K Tziomalos, E Stavrinou, N Katsiki… - Journal of the American …, 2014 - Elsevier
Antihypertensive agents may, even within the same class, exert variable effects on arterial
stiffness variables. Nebivolol could have a better impact than atenolol on arterial stiffness, by …

[HTML][HTML] Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases

GH Oliveira-Paula, R Lacchini, JE Tanus-Santos - Nitric Oxide, 2017 - Elsevier
Nitric oxide (NO) is a vasoactive substance synthesized from l-arginine by neuronal (NOS1),
endothelial (NOS3), and inducible (NOS2) nitric oxide synthases. NOS3 is the most …

[HTML][HTML] Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis

TL Tergast, M Griemsmann, H Wedemeyer… - Scientific Reports, 2023 - nature.com
Patients with decompensated cirrhosis are at risk of developing acute kidney injury (AKI).
Studies have suggested that inhibition of the Renin-Angiotensin System (RAS) has certain …

Rationale for triple‐combination therapy for management of high blood pressure

AH Gradman - The Journal of Clinical Hypertension, 2010 - Wiley Online Library
J Clin Hypertens (Greenwich). The goals of antihypertensive therapy include optimal
reduction in blood pressure (BP) while providing a favorable tolerability profile that promotes …

Role of antihypertensive drugs in arterial 'de-stiffening'and central pulsatile hemodynamics

C Koumaras, M Tzimou, E Stavrinou, T Griva… - American Journal of …, 2012 - Springer
Arterial stiffness is an independent predictor of cardiovascular (CV) morbidity and mortality
in patients with hypertension, as well as a potential therapeutic target. There is increasing …